Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 10 September 2018 the Company bought 538 own shares representing 0.0004% of the share capital of the Company, at a total value of 2 221.94 BGN on the Bulgarian Stock Exchange, the average price per share was 4.13 BGN.

The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.

The total number of treasury shares after these transactions is 9 148 848, representing 6.79% of the share capital of the Company.

Sopharma AD notifies that for August 2018 the Company recorded an increase of sales revenues of 11% compared to the same month of 2017, including 7% decrease of domestic sales and an increase of 25% of export sales.

For the first eight months of this year, revenues from sales of products decreased by 4% compared to the same period of 2017, including 5% decrease of domestic sales and 3% decrease of export sales.